Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (VNDA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
vnda · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 19 Wall Street analysts in the past 3 months
Buy
19 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$21.00
Consensus
$14.25
+139.9% upside
Low
$7.50
Median: $14.25 · Last Close: $5.94
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$14.25
139.9% upside
High Target
$21
253.5%
Low Target
$7.5
26.3%
Current Price
$5.94
as of today
Based on analyst price targets, the VNDA stock price prediction for the next 12 months ranges from $7.5 to $21. The consensus VNDA price forecast of $14.25 implies 139.9% upside from the current price of $5.94.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.81 | ↓ 2.22% |
1-day model range: $5.76–$5.86. Peak: $5.86 (-2.22%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VNDA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-01-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-31 | Jefferies | Maintains | Hold→Hold |
| 2025-12-31 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-30 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Vanda Pharmaceuticals Inc. (VNDA) stock. Of the recent 65 rating actions, 6 were upgrades and 8 were downgrades. 19 analysts currently cover VNDA.
Analyst Recommendation Trends
VNDA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$263M
↓ 38.2% YoY
Revenue Next Year
$356M
↑ 35.6% YoY
EPS This Year
$-2.30
EPS Next Year
$-0.87
↓ 62.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast VNDA EPS of $-2.30 for the current fiscal year, based on estimates from 4 analysts. The VNDA revenue forecast is $263M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The VNDA stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VNDA price target is $14.25 (+139.9% upside), with an analyst consensus of Buy.
The VNDA short-term stock prediction for tomorrow is $5.81 (-2.22%).
Vanda Pharmaceuticals Inc. trades on NASDAQ under the ticker VNDA. The VNDA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 68% of covering analysts.
Frequently asked questions
VNDA forecast · 8 questionsAccording to 19 Wall Street analysts, the average 12-month VNDA price target is $14.25, with a high forecast of $21.00 and a low of $7.50. The median price target is shown in the chart above when available. This implies +139.9% potential upside from the current price of $5.94.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.